Related Experiment Video

Updated: Aug 9, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K

A biomarker-driven therapy for ovarian cancer

Karen O'Leary

    Nature Medicine
    |February 16, 2023
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    Clinical trialsOvarian cancerTargeted therapies

    More Related Videos

    Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
    08:26

    Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

    Published on: February 23, 2024

    2.1K
    Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
    09:40

    Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

    Published on: August 2, 2024

    2.7K

    Related Experiment Videos

    Last Updated: Aug 9, 2025

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
    10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    7.3K
    Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
    08:26

    Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

    Published on: February 23, 2024

    2.1K
    Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
    09:40

    Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

    Published on: August 2, 2024

    2.7K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    7.8K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    7.8K

    Articles linked to this work by shared authors, journal, and citation graph.

    First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial.

    Nature medicine·2026

    Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.

    Nature medicine·2026

    Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

    Nature medicine·2026

    Obinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial.

    Nature medicine·2026

    Type 2 diabetes prevention across the life course.

    Nature medicine·2026

    Large-scale whole-genome sequencing reveals the landscape and health implications of de novo mutations.

    Nature medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us